Comparison of several activity indices for the evaluation of endoscopic activity in UC: Inter- and intraobserver consistency

Inflammatory Bowel Diseases

Volumn 16, Issue 2, 2010, Pages 192-197

  Osada, Taro ^a   Ohkusa, Toshifumi ^b   Yokoyama, Tetsuji ^c   Shibuya, Tomoyoshi ^a   Sakamoto, Naoto ^a   Beppu, Kazuko ^a   Nagahara, Akihito ^a   Otaka, Michiro ^a   Ogihara, Tatsuo ^a   Watanabe, Sumio ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Disease activity; Endoscopic activity index; Kappa statistics; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; DIGESTIVE TRACT ENDOSCOPY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLON; COLONOSCOPY; DATA INTERPRETATION, STATISTICAL; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 73949148671     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21000     Document Type: Article

References (17)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: Final report on a therapeutic trial. BMJ. 1955;1041-1048.
2. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol. 1978;13:833-837.
3. Seo M, Okada M, Yao T, et al. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol. 1992;87:971-976.
4. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29-32.
5. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med. 1994; 330:1841-1845.
6. Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol. 2005;3:11-24.
7. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J. 1955;1041-1048.
8. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 1961;30:393-407.
9. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J. 1964;11:89-92.
10. Blackstone MO. Inflammatory bowel disease. In: Blackstone MO, ed. Endoscopic Interpretation. New York: Raven Press; 1984, p 464-494.
11. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
12. Osada T, Ohkusa T, Okayasu I, et al. Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis. J Gastroenterol Hepatol. 2008;23(suppl 2):S262-267.
13. Agresti A. Categorical data analysis. New York: John Wiley & Sons;1990.
14. Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007;42:16-25.
15. Ando T, Takahashi H, Watanabe O, et al. Magnifying chromoscopy, a novel and useful technique for colonoscopy in ulcerative colitis. World J Gastroenterol. 2007;13:2523-2528.
16. Orlandi F, Brunelli E, Feliciangeli G, et al. Observer agreement in endoscopic assessment of ulcerative colitis. Ital J Gastroenterol Hepatol. 1998;30:539-541.
17. de Lange T, Larsen S, Aabakken L. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol. 2004;4:9.